United States · Bill · HR
H.R. 5467 (106th)
Breast Cancer Prescription Drug Fairness Act
Introduced
12 October 2000
Last action
—
Status
Referred to the Subcommittee on Health and Environment.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Breast Cancer Prescription Drug Fairness Act - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy a covered outpatient drug: (1) in an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries (including the amount sold or distributed to Medicare beneficiaries in a hospice program); and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 12 October 2000
Introduced in House (PDF)
Introduced in House · EN · 12 October 2000
Introduced in House
summary · EN · 12 October 2000
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/106th-congress/house-bill/5467
- Open data entity: https://api.congress.gov/v3/bill/106/hr/5467